Changes in Hong Kong stocks | Path to Health (02587) increased by more than 6% after results, profit attributable to mid-term shareholders increased by nearly 30% year-on-year, and AI-related businesses have been implemented continuously

The Zhitong Finance App learned that Health Path (02587) rose more than 6% after the results. As of press release, it had risen 6.18% to HK$1.81, with a turnover of HK$9.4016 million.

According to the news, on August 28, Health Path announced the interim results for the six months ended June 30, 2026. The group's revenue was 775 million yuan (RMB, same below), up 49.72% year on year; profit attributable to the company's equity shareholders was 9.161 million yuan, up 29.65% year on year; and basic profit per share was 0.01 yuan.

Recently, Health Path issued a supplementary announcement to strategically reallocate approximately HK$107 million of unspent IPO capital. Among them, the original plan was to expand physical pharmacies, recruit on-site health assistants and business representatives on a large scale, and fully shift to AI smart technology research and development and regional ecological layout. It is worth noting that adding AI this time is not conceptual hype; the company's related business has been implemented continuously, and the commercialization path is clear and verifiable.